scholarly journals Removal of an extraluminal gastric gastrointestinal stromal tumor: the role of submucosal tunneling endoscopic resection

Endoscopy ◽  
2017 ◽  
Vol 49 (S 01) ◽  
pp. E11-E13 ◽  
Author(s):  
Hejun Zhou ◽  
Yuyong Tan ◽  
Chunlian Wang ◽  
Jingbo Yang ◽  
Yuqian Zhou ◽  
...  
Endoscopy ◽  
2021 ◽  
Author(s):  
Timothée Wallenhorst ◽  
Jérémie Jacques ◽  
Astrid Lièvre ◽  
Mael Pagenault ◽  
Guillaume Bouguen ◽  
...  

Endoscopy ◽  
2017 ◽  
Vol 49 (08) ◽  
pp. E193-E194 ◽  
Author(s):  
Francesco Azzolini ◽  
Paolo Cecinato ◽  
Elisabetta Froio ◽  
Romano Sassatelli

Author(s):  
A. Ledo-Rodríguez ◽  
J. L. Ulla-Rocha ◽  
R. Baltar-Arias ◽  
S. Vázquez-Rodríguez ◽  
W. Díaz-Saa ◽  
...  

2018 ◽  
Vol 26 (3) ◽  
pp. 215-217
Author(s):  
João Fernandes ◽  
Diogo Libânio ◽  
Sílvia Giestas ◽  
Tarcísio Araújo ◽  
José Ramada ◽  
...  

2015 ◽  
Vol 81 (5) ◽  
pp. AB254-AB255
Author(s):  
Min Jae Yang ◽  
Sun Gyo Lim ◽  
Sung Jae Shin ◽  
Kee Myung Lee

2009 ◽  
Vol 2 ◽  
pp. CGast.S3422
Author(s):  
Ka-Ho Lok

The treatment for localized advance gastrointestinal stromal tumor (GIST) is far from ideal. Up to 50% of patient developed post-operative recurrence and died within 5 years. Recently, imatinib was found to significantly improve recurrence-free survival in post-operative patients. The role of adjuvant therapy in high risk GIST patients is discussed.


Sign in / Sign up

Export Citation Format

Share Document